Uplizd is an enterprise multi-agent AI platform tailored for biopharmaceutical R&D. It accelerates biologics’ and large molecules’ sequence-aware analysis, scientific retrieval, and experiment planning by deploying specialized agents for parallel tasks like liability scanning and literature cross-referencing. Designed to keep scientists in control, Uplizd delivers fully reviewable results with explicit citations and end-to-end provenance in a unified workspace. Built for regulated environments, it features ~3.3-second processing per sequence, native integrations (FASTA, PubMed, Slack), immutable audit logs, RBAC, and flexible deployment (Cloud or On-prem) to ensure strict traceability and governance.

